Trade ASMB anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Assembly Biosciences, Inc. (ASMB) is trading at US$34.12, down 1.95% today as of Aug 28, 09:50 EDT. The company has a market capitalisation of US$700M. Over the past 52 weeks, ASMB has traded between US$20.23 and US$39.71. On Syfe you can trade ASMB with $0 commission and add it to your watchlist.
| Previous close | US$34.80 |
|---|---|
| Market cap | US$700M |
| 52-week range | US$20.23 – US$39.71 |
| Volume | 191.81K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes. The company is partnered with Gilead Sciences to advance current and future antiviral programs across herpesviruses, HBV, and HDV. Assembly Biosciences was founded in 2005 and is headquartered in South San Francisco, CA.
Year: 2010
--Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating
Jun 15, 11:19 AM · MT Newswires
Assembly Biosciences Closes Securities Offering
May 26, 8:48 PM · MT Newswires
Assembly Biosciences Prices $100 Million Offering
May 22, 11:40 AM · MT Newswires
Assembly Biosciences Files $400 Million Mixed Shelf
Mar 19, 9:37 PM · MT Newswires
Assembly Biosciences, Inc. (ASMB) stock is trading at US$34.12, -1.95% from the previous close of US$34.80.
The market cap for Assembly Biosciences, Inc. (ASMB) stock is approximately US$700M.
The 52-week high for Assembly Biosciences, Inc. (ASMB) stock is US$39.71.
The 52-week low for Assembly Biosciences, Inc. (ASMB) stock is US$20.23.
Assembly Biosciences, Inc. (ASMB) does not currently pay a dividend.
Stay on top of ASMB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
